Quality Metrics Training

The FDA has shifted from routine biannual inspections to a risk-based inspection model under the Food and Drug Administration Safety and Innovation Act (FDASIA). Quality Metrics now play a vital role in demonstrating the strength of a pharmaceutical manufacturer’s quality system.
This course enables pharmaceutical companies to design, track, and interpret Quality Metrics that drive continuous improvement, support inspection readiness, and strengthen the internal quality culture. Companies exporting to the U.S. also benefit from reduced inspection frequency and risk-based inspection scheduling through the adoption of strong Quality Metrics programmes.